187 related articles for article (PubMed ID: 22887469)
21. Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo.
Zhang Y; Kaplan-Lefko PJ; Rex K; Yang Y; Moriguchi J; Osgood T; Mattson B; Coxon A; Reese M; Kim TS; Lin J; Chen A; Burgess TL; Dussault I
Cancer Res; 2008 Aug; 68(16):6680-7. PubMed ID: 18701492
[TBL] [Abstract][Full Text] [Related]
22. RON, a tyrosine kinase receptor involved in tumor progression and metastasis.
Camp ER; Liu W; Fan F; Yang A; Somcio R; Ellis LM
Ann Surg Oncol; 2005 Apr; 12(4):273-81. PubMed ID: 15827676
[TBL] [Abstract][Full Text] [Related]
23. EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cells.
Park JS; Khoi PN; Joo YE; Lee YH; Lang SA; Stoeltzing O; Jung YD
Int J Oncol; 2013 Mar; 42(3):1120-6. PubMed ID: 23337910
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
Camp ER; Yang A; Gray MJ; Fan F; Hamilton SR; Evans DB; Hooper AT; Pereira DS; Hicklin DJ; Ellis LM
Cancer; 2007 Mar; 109(6):1030-9. PubMed ID: 17311308
[TBL] [Abstract][Full Text] [Related]
25. RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant.
Eckerich C; Schulte A; Martens T; Zapf S; Westphal M; Lamszus K
J Neurochem; 2009 May; 109(4):969-80. PubMed ID: 19519771
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma.
Wang J; Rajput A; Kan JL; Rose R; Liu XQ; Kuropatwinski K; Hauser J; Beko A; Dominquez I; Sharratt EA; Brattain L; Levea C; Sun FL; Keane DM; Gibson NW; Brattain MG
J Biol Chem; 2009 Apr; 284(16):10912-22. PubMed ID: 19224914
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-375 Functions as a Tumor-Suppressor Gene in Gastric Cancer by Targeting Recepteur d'Origine Nantais.
Lian S; Park JS; Xia Y; Nguyen TT; Joo YE; Kim KK; Kim HK; Jung YD
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27689991
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidic Acid Upregulates Recepteur D'origine Nantais Expression and Cell Invasion via Egr-1, AP-1, and NF-κB Signaling in Bladder Carcinoma Cells.
Khoi PN; Li S; Thuan UT; Sah DK; Kang TW; Nguyen TT; Lian S; Xia Y; Jung YD
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906413
[TBL] [Abstract][Full Text] [Related]
29. Abnormal expression of HAX‑1 is associated with cellular proliferation and migration in human hypopharyngeal squamous cell carcinoma.
Wu H; Chen J; Wang Q; Yin Y; Da P; Le H; Zhang Z; Qiu X
Mol Med Rep; 2017 Oct; 16(4):4664-4670. PubMed ID: 28791389
[TBL] [Abstract][Full Text] [Related]
30. Activation of the RON receptor tyrosine kinase attenuates transforming growth factor-beta1-induced apoptotic death and promotes phenotypic changes in mouse intestinal epithelial cells.
Wang D; Shen Q; Xu XM; Chen YQ; Wang MH
Carcinogenesis; 2005 Jan; 26(1):27-36. PubMed ID: 15447977
[TBL] [Abstract][Full Text] [Related]
31. Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells.
Narasimhan M; Ammanamanchi S
Cancer Res; 2008 Jul; 68(13):5185-92. PubMed ID: 18593918
[TBL] [Abstract][Full Text] [Related]
32. Expression of RON in colorectal cancer and its relationships with tumor cell behavior and prognosis.
Park YL; Lee GH; Kim KY; Myung E; Kim JS; Myung DS; Park KJ; Cho SB; Lee WS; Jung YD; Kim HS; Joo YE
Tumori; 2012; 98(5):652-62. PubMed ID: 23235762
[TBL] [Abstract][Full Text] [Related]
33. RON and RONΔ160 promote gastric cancer cell proliferation, migration, and adaption to hypoxia via interaction with β-catenin.
Zhou D; Huang L; Zhou Y; Wei T; Yang L; Li C
Aging (Albany NY); 2019 May; 11(9):2735-2748. PubMed ID: 31085796
[TBL] [Abstract][Full Text] [Related]
34. FoxM1 overexpression promotes cell proliferation and migration and inhibits apoptosis in hypopharyngeal squamous cell carcinoma resulting in poor clinical prognosis.
Chen Y; Liu Y; Ni H; Ding C; Zhang X; Zhang Z
Int J Oncol; 2017 Oct; 51(4):1045-1054. PubMed ID: 28848994
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
Wang MH; Wang D; Chen YQ
Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
[TBL] [Abstract][Full Text] [Related]
36. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
Wang MH; Yao HP; Zhou YQ
Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
[TBL] [Abstract][Full Text] [Related]
37. Activation of RON differentially regulates claudin expression and localization: role of claudin-1 in RON-mediated epithelial cell motility.
Zhang K; Yao HP; Wang MH
Carcinogenesis; 2008 Mar; 29(3):552-9. PubMed ID: 18204077
[TBL] [Abstract][Full Text] [Related]
38. RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells.
Xu XM; Wang D; Shen Q; Chen YQ; Wang MH
Oncogene; 2004 Nov; 23(52):8464-74. PubMed ID: 15378025
[TBL] [Abstract][Full Text] [Related]
39. PCDH20 acts as a tumour-suppressor gene through the Wnt/β-catenin signalling pathway in hypopharyngeal squamous cell carcinoma.
Gong Z; Hu G
Cancer Biomark; 2019; 26(2):209-217. PubMed ID: 31450490
[TBL] [Abstract][Full Text] [Related]
40. The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors.
Fialin C; Larrue C; Vergez F; Sarry JE; Bertoli S; Mansat-De Mas V; Demur C; Delabesse E; Payrastre B; Manenti S; Roche S; Récher C
Leukemia; 2013 Feb; 27(2):325-35. PubMed ID: 22902361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
